ISSN: 2228-5881 eISSN: 2251-7308

Adv Pharm Bull. 2015;5(5): 605-614. doi: 10.15171/apb.2015.082

PMID: 26793605 PMCID: PMC4708030

Review Article

Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases

Akbar Mohammad Hosseini ¹, Jafar Majidi ¹ * , Behzad Baradaran ¹ * , Mehdi Yousefi ^2,1

Cited by CrossRef: 81

1- Zhao L, Fu Z. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy. Journal of Immunology Research. 2018;2018:1 [Crossref]

2- Aslaksen S, Wolff A, Vigeland M, Breivik L, Sheng Y, Oftedal B, Artaza H, Skinningsrud B, Undlien D, Selmer K, Husebye E, Bratland E. Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease. Journal of Translational Autoimmunity. 2019;1:100005 [Crossref]

3- Pearson J, Wong F, Wen L. Crosstalk between circadian rhythms and the microbiota. Immunology. 2020;161(4):278 [Crossref]

4- Li Y, Sun H, Yin Z, Guo X, Yan J. Anti-Inflammatory Effects of Cerium Dioxide Nanoparticles on Peritonitis in Rats Induced by Staphylococcus epidermidis Infection. Advances in Polymer Technology. 2020;2020:1 [Crossref]

5- Mortazavi Jahromi S, Jamshidi M, Yousefi M, Navabi S, Motamed N, Zavareh F, Mirshafiey A. Inhibitory effect of G2013 molecule as a novel immunomodulatory agent, on miR-155 gene expression in HEK-Blue hTLR4 cell line. Eur J Inflamm. 2016;14(2):86 [Crossref]

6- Deshmukh A, Pereira A, Geraci N, Tzvetkov E, Przetak M, Catalina M, Morand E, Bender A, Vaidyanathan B. Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases. J Pharmacol Exp Ther. 2024;388(3):751 [Crossref]

7- Han J, Tong H, Cheng S, Yang L, Chen H, Chen J, Chen X. Effect of Kangshuanyihao Formula on the Inflammatory Reaction and SIRT1/TLR4/NF-κB Signaling Pathway in Endothelial Injury. Evidence-Based Complementary and Alternative Medicine. 2017;2017:1 [Crossref]

8- Pahlavan Y, Samadi N, Ansarin K, Khabbazi A. Phosphorylation Modulates Survivin Function in Behcet’s Disease. Adv Pharm Bull. 2020;10(2):278 [Crossref]

9- Lapuente J, Blázquez-Martínez A, Marco-Brualla J, Gómez G, Desportes P, Sanz J, Fernández P, García-Gil M, Bermejo F, San Martín J, Algaba A, De Gregorio J, Lapuente D, De Gregorio A, Lapuente B, Andrés M, Anel A. Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM). Biomolecules. 2022;12(4):534 [Crossref]

10- Amraotkar A, Bushau-Sprinkle A, Keith R, Hamorsky K, Palmer K, Gao H, Rai S, Bhatnagar A. Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination. Vaccines. 2022;10(8):1363 [Crossref]

11- Richards C, McRae S, Ranger A, Klegeris A. Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses. 2023;34(5):533 [Crossref]

12- Oakes R, Froimchuk E, Jewell C. Engineering Biomaterials to Direct Innate Immunity. Advanced Therapeutics. 2019;2(6) [Crossref]

13- Taylor E, Wolf V, Dent E, Ryan M. Mechanisms of hypertension in autoimmune rheumatic diseases. British J Pharmacology. 2019;176(12):1897 [Crossref]

14- Besednova N, Andryukov B, Zaporozhets T, Kuznetsova T, Kryzhanovsky S, Ermakova S, Galkina I, Shchelkanov M. Molecular Targets of Brown Algae Phlorotannins for the Therapy of Inflammatory Processes of Various Origins. Marine Drugs. 2022;20(4):243 [Crossref]

15- Mertowski S, Grywalska E, Ludian J, Grafka A, Pęksa B, Roliński J, Załuska W. The significance of Toll-like receptors in selected nephropathies. diagn lab. 2019;55(2):107 [Crossref]

16- Lee F, Harris C, Alper S. RNA Binding Proteins that Mediate LPS-induced Alternative Splicing of the MyD88 Innate Immune Regulator. Journal of Molecular Biology. 2024;436(8):168497 [Crossref]

17- Tröscher A, Wimmer I, Quemada-Garrido L, Köck U, Gessl D, Verberk S, Martin B, Lassmann H, Bien C, Bauer J. Microglial nodules provide the environment for pathogenic T cells in human encephalitis. Acta Neuropathol. 2019;137(4):619 [Crossref]

18- Ziegler S, Feldmann C, Hagen S, Richert L, Barkhausen T, Goletzke J, Jazbutyte V, Martrus G, Salzberger W, Renné T, Hecher K, Diemert A, Arck P, Altfeld M. Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy. Journal of Reproductive Immunology. 2018;128:30 [Crossref]

19- Rahman N, Begum S, Khan A, Afridi S, Khayam Sahibzada M, Atwah B, Alhindi Z, Khan H. An insight in Salmonella typhi associated autoimmunity candidates' prediction by molecular mimicry. Computers in Biology and Medicine. 2022;148:105865 [Crossref]

20- Guo A, Tan Y, Liu C, Zheng X. MST-4 and TRAF-6 expression in the peripheral blood mononuclear cells of patients with Graves’ disease and its significance. BMC Endocr Disord. 2017;17(1) [Crossref]

21- Cosgrove H, Gingras S, Kim M, Bastacky S, Tilstra J, Shlomchik M. B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice. 2023;8(16) [Crossref]

22- Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, Libert C, Smets I, Goris A, Wouters C, Matthys P. IFN‐γ stimulates CpG‐induced IL‐10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48(9):1506 [Crossref]

23- Suhail Wadi J, AL-Duhaidahawi D, salam abdullah S, Jabir M, Najim M, Farhan Jawad S, Hamzah S, Abdul Qais F. Exploring the interaction between 3-D structure of TLR 9 and prostaglandin analogues. Arabian Journal of Chemistry. 2023;16(5):104692 [Crossref]

24- Alkader D, Asadi N, Solangi U, Singh R, Rasuli S, Farooq M, Raheela F, Waseem R, Gilani S, Abbas K, Ahmed M, Tanoh D, Shah H, Dulal A, Hussain M, Talpur A. Exploring the role of gut microbiota in autoimmune thyroid disorders: a systematic review and meta-analysis. Front Endocrinol. 2023;14 [Crossref]

25- Kızıldağ S, Arslan S, Özbilüm N, Engin A, Bakır M. Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. Journal of Medical Virology. 2018;90(1):19 [Crossref]

26- Trojan A, Lone Y, Briceno I, Trojan J. Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma. CMC. 2024;31(15):1983 [Crossref]

27- Shakya A, Nandakumar K. Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases. Trends in Biotechnology. 2018;36(7):686 [Crossref]

28- Frizinsky S, Haj-Yahia S, Machnes Maayan D, Lifshitz Y, Maoz-Segal R, Offengenden I, Kidon M, Agmon-Levin N. The innate immune perspective of autoimmune and autoinflammatory conditions. 2019;58(Supplement_6):vi1 [Crossref]

29- Mahdy S, Abd Elkader N, Kassim N, ElHady M. Genetic variation in toll-like receptor 4 gene with primary antiphospholipid syndrome susceptibility: a cohort of Egyptian patients. Egypt J Med Hum Genet. 2022;23(1) [Crossref]

30- Huang S, Mei H, Zhang D, Shi T, Chen L, Kuang Z, Heng Y, Pan X, Lu L. Subtle differences in chemical pattern between human toll‐like receptor 8 agonists and antagonists: Emerging chemical patterns analysis. Chem Biol Drug Des. 2019;94(4):1824 [Crossref]

31- McGurran H, Kumbol V, Krüger C, Wallach T, Lehnardt S. miR-154-5p Is a Novel Endogenous Ligand for TLR7 Inducing Microglial Activation and Neuronal Injury. Cells. 2024;13(5):407 [Crossref]

32- Root-Bernstein R. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. IJMS. 2021;22(4):2108 [Crossref]

33- Souza-Costa L, Andrade-Chaves J, Andrade J, Costa V, Franco L. Uncovering new insights into the role of the ubiquitin ligase Smurf1 on the regulation of innate immune signaling and resistance to infection. Front Immunol. 2023;14 [Crossref]

34- McKinnon J, Santiaguel J, Murta de Oliveira C, Yu D, Khursheed M, Moreau F, Klopp‐Schulze L, Shaw J, Roy S, Kao A. Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial. Clinical Translational Sci. 2023;16(12):2640 [Crossref]

35- Golden L, Itoh Y, Itoh N, Iyengar S, Coit P, Salama Y, Arnold A, Sawalha A, Voskuhl R. Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes. Proc Natl Acad Sci USA. 2019;116(52):26779 [Crossref]

36- Dela Justina V, Giachini F, Priviero F, Webb R. Double-stranded RNA and Toll-like receptor activation: a novel mechanism for blood pressure regulation. 2020;134(2):303 [Crossref]

37- Robinet M, Maillard S, Cron M, Berrih-Aknin S, Le Panse R. Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models. Clinic Rev Allerg Immunol. 2017;52(1):133 [Crossref]

38- Hajiasgharzadeh K, Sadigh‐Eteghad S, Mansoori B, Mokhtarzadeh A, Shanehbandi D, Doustvandi M, Asadzadeh Z, Baradaran B. Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes?. Journal Cellular Physiology. 2019;234(9):14666 [Crossref]

39- Roozbehkia M, Mahmoudi M, Aletaha S, Rezaei N, Fattahi M, Jafarnezhad-Ansariha F, Barati A, Mirshafiey A. The potent suppressive effect of β- d -mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients. International Immunopharmacology. 2017;52:191 [Crossref]

40- Al-Humairi R, Al-Musawi M, Ad'hiah A. Bidirectional expression of Toll-like receptor 7 gene in urinary bladder cancer and urinary tract infection of Iraqi patients. Gene Reports. 2019;17:100491 [Crossref]

41- Abdelwahab A, Palosaari S, Abdelwahab S, Rifaai R, El-Tahawy N, Saber E, Nousiainen T, Valkealahti M, Huhtakangas J, Karttunen T, Lehenkari P. Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report. Autoimmunity. 2021;54(1):23 [Crossref]

42- Root-Bernstein R. Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions. IJMS. 2020;21(13):4645 [Crossref]

43- Feng J, Lin P, Wang Y, Zhang Z. Molecular characterization, expression patterns, and functional analysis of toll-interacting protein (Tollip) in Japanese eel Anguilla japonica. Fish & Shellfish Immunology. 2019;90:52 [Crossref]

44- Qiao Z, Zhao Y, Wang M, Cao J, Chang M, Yun S, Cheng Y, Cheng F, Feng C. Effects of Sparassis latifolia neutral polysaccharide on immune activity via TLR4-mediated MyD88-dependent and independent signaling pathways in RAW264.7 macrophages. Front Nutr. 2022;9 [Crossref]

45- Yang X, Cheng Y, Li C. The role of TLRs in cervical cancer with HPV infection: a review. Sig Transduct Target Ther. 2017;2(1) [Crossref]

46- Bargiel P, Szczuko M, Stachowska L, Prowans P, Czapla N, Markowska M, Petriczko J, Kledzik J, Jędrzejczyk-Kledzik A, Palma J, Zabielska P, Maciejewska-Markiewicz D. Microbiome Metabolites and Thyroid Dysfunction. JCM. 2021;10(16):3609 [Crossref]

47- Lee F, Davidson K, Harris C, McClendon J, Janssen W, Alper S. NF-κB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages. Journal of Biological Chemistry. 2020;295(18):6236 [Crossref]

48- Dvornikova K, Bystrova E, Platonova O, Churilov L. Polymorphism of toll-like receptor genes and autoimmune endocrine diseases. Autoimmunity Reviews. 2020;19(4):102496 [Crossref]

49- Farooq M, Batool M, Kim M, Choi S. Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies. Front Cell Dev Biol. 2021;9 [Crossref]

50- Vijay K. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. International Immunopharmacology. 2018;59:391 [Crossref]

51- Echavarria R, Cardona-Muñoz E, Ortiz-Lazareno P, Andrade-Sierra J, Gómez-Hermosillo L, Casillas-Moreno J, Campos-Bayardo T, Román-Rojas D, García-Sánchez A, Miranda-Díaz A. The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis. IJMS. 2023;24(20):15234 [Crossref]

52- Khalil M, Monir Mansour M, Bakrey Hamed Ata M, Elaskary S, Genena S. Toll-like receptor 7 and tumor necrosis factor alpha polymorphisms in Egyptian patients with autoimmune thyroid diseases. Journal of Immunoassay and Immunochemistry. 2024;45(2):93 [Crossref]

53- Alajoleen R, Oakland D, Estaleen R, Shakeri A, Lu R, Appiah M, Sun S, Neumann J, Kawauchi S, Cecere T, McMillan R, Reilly C, Luo X. Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model. Front Immunol. 2024;15 [Crossref]

54- Hassan A, Shoeib S, Abdelmohsen E, Nazir A, Dawood A, Gamal H, Abdelhafez M. Toll-Like Receptor 9 (TLR9) Gene C/T (rs352140) Polymorphisms in Adult Primary Immune Thrombocytopenia. Clin Appl Thromb Hemost. 2020;26:107602962094005 [Crossref]

55- Mertowski S, Lipa P, Morawska I, Niedźwiedzka-Rystwej P, Bębnowska D, Hrynkiewicz R, Grywalska E, Roliński J, Załuska W. Toll-Like Receptor as a Potential Biomarker in Renal Diseases. IJMS. 2020;21(18):6712 [Crossref]

56- Mishra V, Pathak C. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer. International Journal of Biological Macromolecules. 2019;122:425 [Crossref]

57- Griffin J, Song J, Sestak J, DeKosky B, Berkland C. Linking autoantigen properties to mechanisms of immunity. Advanced Drug Delivery Reviews. 2020;165-166:105 [Crossref]

58- Mortazavi-Jahromi S, Jamshidi M, Farazmand A, Aghazadeh Z, Yousefi M, Mirshafiey A. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions. Pharmacological Reports. 2017;69(3):479 [Crossref]

59- Gershony L, Belanger J, Hytönen M, Lohi H, Famula T, Oberbauer A. Genetic characterization of Addison’s disease in Bearded Collies. BMC Genomics. 2020;21(1) [Crossref]

60- Brutkiewicz R. Cell Signaling Pathways That Regulate Antigen Presentation. 2016;197(8):2971 [Crossref]

61- Zhang S, Hu Z, Tanji H, Jiang S, Das N, Li J, Sakaniwa K, Jin J, Bian Y, Ohto U, Shimizu T, Yin H. Small-molecule inhibition of TLR8 through stabilization of its resting state. Nat Chem Biol. 2018;14(1):58 [Crossref]

62- Merrheim J, Villegas J, Van Wassenhove J, Khansa R, Berrih-Aknin S, le Panse R, Dragin N. Estrogen, estrogen-like molecules and autoimmune diseases. Autoimmunity Reviews. 2020;19(3):102468 [Crossref]

63- Yang Y, Luo S, Huang J, Xiao Y, Fu Y, Liu W, Yin H. Photoactivation of Innate Immunity Receptor TLR8 in Live Mammalian Cells by Genetic Encoding of Photocaged Tyrosine. ChemBioChem. 2022;23(4) [Crossref]

64- Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. WJH. 2016;8(32):1354 [Crossref]

65- Lai R, Gu M, Jiang W, Lin W, Xu P, Liu Z, Huang H, An H, Wang X. Raf Kinase Inhibitor Protein Preferentially Promotes TLR3-Triggered Signaling and Inflammation. 2017;198(10):4086 [Crossref]

66- Mortazavi-Jahromi S, Farazmand A, Motamed N, Navabi S, Mirshafiey A. Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway. International Immunopharmacology. 2018;55:323 [Crossref]

67- Tilstra J, John S, Gordon R, Leibler C, Kashgarian M, Bastacky S, Nickerson K, Shlomchik M. B cell–intrinsic TLR9 expression is protective in murine lupus. 2020;130(6):3172 [Crossref]

68- Huang Z, He A, Wang J, Lu H, Xu X, Zhang R, Liao W, Feng Q, Wu L. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma. CBM. 2022;34(1):77 [Crossref]

69- Ng J, Chong E, Lee P. An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect. CPB. 2022;23(13):1596 [Crossref]

70- Wajda A, Walczyk M, Dudek E, Stypińska B, Lewandowska A, Romanowska-Próchnicka K, Chojnowski M, Olesińska M, Paradowska-Gorycka A. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement. IJMS. 2022;23(18):10731 [Crossref]

71- Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules—New Approaches to Treat Sepsis?. IJMS. 2017;18(3):476 [Crossref]

72- Tesovnik T, Kovač J, Pohar K, Hudoklin S, Dovč K, Bratina N, Trebušak Podkrajšek K, Debeljak M, Veranič P, Bosi E, Piemonti L, Ihan A, Battelino T. Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes. Front Cell Dev Biol. 2020;8 [Crossref]

73- Fisher J, Chroust Z, Onyoni F, Soong L. Pattern Recognition Receptors in Innate Immunity to Obligate Intracellular Bacteria. Zoonoses. 2021;1(1) [Crossref]

74- Lapuente J, Gómez G, Marco-Brualla J, Fernández P, Desportes P, Sanz J, García-Gil M, Bermejo F, San Martín J, Algaba A, De Gregorio J, Lapuente D, De Gregorio A, Lapuente B, Gómez S, Andrés M, Anel A. Evaluation in a Cytokine Storm Model In Vivo of the Safety and Efficacy of Intravenous Administration of PRS CK STORM (Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells). Biomedicines. 2022;10(5):1094 [Crossref]

75- Sawicka-Gutaj N, Gruszczyński D, Zawalna N, Nijakowski K, Muller I, Karpiński T, Salvi M, Ruchała M. Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review. IJMS. 2022;23(21):13450 [Crossref]

76- Bruno K, Woller S, Miller Y, Yaksh T, Wallace M, Beaton G, Chakravarthy K. Targeting toll-like receptor-4 (TLR4)—an emerging therapeutic target for persistent pain states. Pain. 2018;159(10):1908 [Crossref]

77- Zhang Y, Liu J, Wang C, Liu J, Lu W. Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease. Front Immunol. 2021;12 [Crossref]

78- Klopp‐Schulze L, Shaw J, Dong J, Khandelwal A, Vazquez‐Mateo C, Goteti K. Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need. Clin Pharma and Therapeutics. 2022;112(2):297 [Crossref]

79- Davies R, Sarkar I, Hammenfors D, Bergum B, Vogelsang P, Solberg S, Gavasso S, Brun J, Jonsson R, Appel S. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome. Front Immunol. 2019;10 [Crossref]

80- Wu C, Deng H, Li D, Fan L, Yao D, Zhi X, Mao H, Hu C. Ctenopharyngodon idella Tollip regulates MyD88-induced NF-κB activation. Developmental & Comparative Immunology. 2021;123:104162 [Crossref]

81- Zadeh-Vakili A, Faam B, Afgar A, Razmpoosh E, zarkesh M, Amouzegar A. A systematic review of dysregulated microRNAs in Hashimoto’s thyroiditis. Endocrine. 2024; [Crossref]

82- Kutlutürk I, Tokuç E, Karabaş L, Rückert R, Kaya M, Karagöz A, Munk M. How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling. Immunol Res. 2024;72(1):50 [Crossref]